<i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target CholangiocarcinomaNicholas T. Younger, Luke Boulter, Mollie L. Wilson et al.|Cancer Research|2022Cited by 17
Data from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target CholangiocarcinomaNicholas T. Younger, Luke Boulter, Mollie L. Wilson et al.|Unknown|2023Cited by 0
Supplementary Data from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target CholangiocarcinomaNicholas T. Younger, Luke Boulter, Mollie L. Wilson et al.|Unknown|2023Cited by 0
Supplementary Data from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target CholangiocarcinomaNicholas T. Younger, Luke Boulter, Mollie L. Wilson et al.|Unknown|2023Cited by 0
Supplementary Data from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target CholangiocarcinomaNicholas T. Younger, Luke Boulter, Mollie L. Wilson et al.|Unknown|2023Cited by 0